2BB score and signals
Sana Biotechnology, Inc.’s current 2BB score is 45 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 47 | Moderate |
| Momentum | 32 | Weakening |
| Financial strength | 1 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 45 | Moderate |
Company facts
| CEO | Steve Harr |
| Headquarters | Seattle, Washington, United States |
| Founded | 2018 |
| Employees | 142 |
| 52-week range | $2.61 – $6.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.1501 | — | $0.00 |
| 2026-08-10 | -0.13 | -0.1487 | $0.00 | $0.00 |
| 2026-05-11 | -0.17 | -0.173 | $0.00 | $0.00 |
| 2026-03-03 | -0.21 | -0.1355 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish